The endocannabinoid system as a therapeutic target in neuropathic pain: a review
Expert Opinion on Therapeutic Targets,
Journal Year:
2024,
Volume and Issue:
28(9), P. 739 - 755
Published: Sept. 1, 2024
This
review
highlights
the
critical
role
of
endocannabinoid
system
(ECS)
in
regulating
neuropathic
pain
and
explores
therapeutic
potential
cannabinoids.
Understanding
mechanisms
ECS,
including
its
receptors,
endogenous
ligands,
enzymatic
routes,
can
lead
to
innovative
treatments
for
chronic
pain,
offering
more
effective
therapies
conditions.
bridges
gap
between
preclinical
studies
clinical
applications
by
emphasizing
ECS
modulation
better
management
outcomes.
Language: Английский
The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Published: May 13, 2024
The
endocannabinoid
system
(ECS)
is
a
complex
neuromodulatory
network
in
the
human
body
that
have
enormous
impact
developing
central
nervous
system,
as
well
modulates
various
physiological
processes.
ECS
made
up
of
anandamide,
2-arachidonoylglycerol
(2-AG),
which
are
responsible
for
synthesis
and
degradation
endocannabinoids,
enzymes
such
FAAH
MAGL
ensures
precise
control
over
levels.
relies
on
CB1
receptors
found
(CNS),
CB2
peripheral
immune
cells.
Dysregulation
has
been
associated
with
several
health
conditions,
prompting
investigations
into
its
association
phytocannabinoids
to
harness
their
therapeutic
potential.
intricately
linked
it
known
modulate
neuronal
activities
CNS,
influencing
pain
mood
modulation.
also
neuropathies-peripheral
nerve
damage
leading
symptoms
weakness,
numbness
evidenced
diabetic
neuropathy,
Guillain-Barré
Syndrome,
carpal
tunnel
syndrome,
postherpetic
neuralgia.
focus
this
review
interplay
between
anandamide
amidohydrolase
elucidating
roles
regulation,
inflammation,
specific
neuropathies.
knowledge
generated
expected
broad
implications,
providing
comprehensive
insights
neuropathic
conditions
how
improve
them.
Ultimately,
understanding
may
lead
more
effective
treatments
improved
quality
life
individuals
affected
by
these
conditions.
Language: Английский
Prolonged CBD Pressure Mediates Higher Expression of flgA in <em>Salmonella</em> typhimurium
Iddrisu Ibrahim,
No information about this author
Alexa Mathias,
No information about this author
D. C. Johnson
No information about this author
et al.
Published: May 29, 2024
Salmonella
Typhimurium
is
a
typical
Gram-Negative
bacterium
associated
with
food-borne
illness
threatening
public
health.
This
pathogen
reported
to
have
caused
millions
of
infections
and
thousands
hospitalizations
yearly
in
the
United
States
alone.
has
sophisticated
array
virulent
factors,
including
its
flagella,
which
contributes
significantly
pathogenicity.
Cannabidiol
(CBD),
non-psychoactive
component
cannabis
plant,
attracted
interest
many
researchers
recently
because
antimicrobial
properties.
With
growing
exploring
CBD’s
properties,
we,
this
study,
delved
into
unravelling
how
prolonged
exposure
CBD
influences
expression
flgA
gene.
We
hypothesized
that
may
result
upregulation,
causing
bacteria
withstand
various
stresses
potentially
enhance
survival
rates
employed
several
assays,
such
as
mRNA
expression,
motility
pH
induction
nutrient
starvation
interventions,
biofilm
analysis,
explore
influence
on
pathophysiology
Typhimurium.
Our
findings
reveal
CBD-resistant
strains
exhibit
enhanced
resilience
extreme
levels
survive
poorly
under
starvation,
more
robust
formation
compared
susceptible
strains.
The
results
contribute
broader
comprehension
resistance
mechanisms
bacteria.
work
provides
insight
potential
therapeutic
interventions
for
controlling
bacterial
infections.
study
also
underscores
essence
novel
alternative
agents
tackle
ever-persistence
antibiotic
resistance.
Language: Английский